Adipose Tissue Derived Stem Cell Global Market Report 2025
상품코드:1889292
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
지방 조직 유래 줄기세포 시장 규모는 최근 급속히 확대되고 있습니다. 2024년 10억 7,000만 달러로 평가되었고, 2025년에는 12억 달러에 달할 것으로 추정되며, CAGR 12.7%로 성장할 전망입니다. 지난 수년간의 성장은 재생 의학 부문에서의 조사 활동 증가, 만성 및 변성 질환의 유병률 증가, 저침습 치료에 대한 수요 증가, 미용 및 성형 외과 부문에서의 용도 확대, 줄기세포 연구에 대한 정부와 민간 자금 증가와 관련이 있습니다.
지방 조직 유래 줄기세포 시장 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 19억 1,000만 달러에 달할 것으로 예측되며, CAGR 12.3%로 성장할 전망입니다. 예측 기간의 성장은 만성 및 변성 질환의 지속적인 증가, 고령화 인구 확대에 따른 재생의료 수요 증가, 지방 조직 유래 치료의 임상검사 및 규제 승인 증가, 바이오뱅크 및 줄기세포 보존 시설 확충, 줄기세포 기반 제품의 상업화 진전에 의해 견인될 가능성이 있습니다. 예측 기간 주요 동향으로는 개별화 재생의료의 진전, 임상 용도를 위한 제조 기술 및 스케일업 진보, 동종 지방 유래 제품 개발에서의 혁신, 자동화 및 폐쇄계 바이오리액터의 통합, 규제 채널 및 표준화의 진전 등을 들 수 있습니다.
대체 요법에 대한 수요 증가는 향후 지방 조직 유래 줄기세포 시장의 성장에 크게 기여할 것으로 예측됩니다. 대체 요법은 치료 및 전반적인 건강 증진을 촉진하기 위해 표준 의료 행위 대신 또는 함께 사용되는 비 전통적인 치료를 의미합니다. 기존의 의약품에 잠재적인 부작용이 있다는 것에 대한 소비자의 인식이 높아지고 있기 때문에 이러한 치료에 대한 수요가 증가하고 있으며, 보다 많은 개인이 장기적인 건강을 지지하는 자연스럽고 홀리스틱한 치료 선택지를 요구하게 되고 있습니다. 지방 조직 유래 줄기세포는 자연적인 조직 재생 및 치료를 촉진하고 다양한 만성 질환과 퇴행성 질환의 치료에 저침습적이고 합리적인 접근법을 제공함으로써 이 동향을 따릅니다. 예를 들어 호주산업단체인 보완의료협회(CMA)가 2023년 12월 발표한 보고서에 따르면 보완의료 산업은 건강 및 웰니스를 지원하는 중요한 역할을 하는 동시에 국가경제에 크게 공헌하고 있으며 2023년 연간 수익은 약 64억 달러에 달했고, 2022년 대비 7% 증가했습니다. 따라서 대체요법에 대한 수요 증가가 지방 조직 유래 줄기세포 시장의 확대를 이끌 것으로 예측됩니다.
지방 조직 유래 줄기세포 시장의 주요 기업은 재생의료 부문에 있어서의 치료 효과, 안전성, 임상 성과의 향상을 목표로, 간엽계 줄기세포(MSC) 등 줄기세포 기술의 진보에 주력하고 있습니다. 중간엽 줄기세포(MSC)는 골세포, 연골세포, 지방세포 등 다양한 세포로 분화 가능한 다능성 간질세포입니다. 이들은 조직 복구, 재생, 면역 조절에 중요한 역할을 하기 때문에 재생 의료 및 치료 용도에서 가치가 높습니다. 예를 들어, 2023년 4월에는 지방 유래 줄기세포의 보존 및 치료를 전문으로 하는 미국의 바이오테크놀러지 기업 셀텍스 세라퓨틱스사가 임상 용도를 위한 지방 유래 줄기세포의 생존율과 치료 가능성을 높이는 독자 세포 증식 기술의 진전을 발표했습니다. 이 진전은 재생의료 시장에서 동사의 지위 강화를 위한 중요한 전진을 보이는 것과 동시에 다양한 만성 및 변성 질환에서 환자의 치료 성과 향상을 목표로 하는 안전하고 효과적인 지방 유래 줄기세포 치료의 선구적 개발에 대한 대처를 실증하는 것이었습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 지방 조직 유래 줄기세포 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 지방 조직 유래 줄기세포 시장 : 성장률 분석
세계의 지방 조직 유래 줄기세포 시장 실적 : 규모 및 성장(2019-2024년)
세계의 지방 조직 유래 줄기세포 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 지방 조직 유래 줄기세포 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 지방 조직 유래 줄기세포 시장 : 세포 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
중간엽 줄기세포
지방 유래 줄기세포
지방 간질 세포
세계의 지방 조직 유래 줄기세포 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
자기유래 줄기세포
동종 줄기세포
세계의 지방 조직 유래 줄기세포 시장 : 용도별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
재생 의료
조직 공학
세포 치료
기타
세계의 지방 조직 유래 줄기세포 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
바이오테크놀러지 기업
학술연구기관
세계의 지방 조직 유래 줄기세포 시장 : 간엽계 줄기세포 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
골수 유래 간엽계 줄기세포
제대 유래 간엽계 줄기세포
태반 유래 간엽계 줄기세포
치수 유래 간엽계 줄기세포
세계의 지방 조직 유래 줄기세포 시장 : 지방 유래 줄기세포 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
피하 지방 유래 줄기세포
내장 지방 유래 줄기세포
혈관 주위 지방 유래 줄기세포
갈색 지방 조직 유래 줄기세포
세계의 지방 조직 유래 줄기세포 시장 : 지방 간질 세포 유형별 세분화 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
간질 혈관 분획 세포
전지방세포 간질 세포
내피 전구 간질 세포
주피세포 간질 세포
제7장 지역별 및 국가별 분석
세계의 지방 조직 유래 줄기세포 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 지방 조직 유래 줄기세포 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
지방 조직 유래 줄기세포 시장 : 경쟁 구도
지방 조직 유래 줄기세포 시장 : 기업 프로파일
Thermo Fisher Scientific Inc.
Takeda Pharmaceutical Company Limited
Merck KGaA
Lonza Group AG
STEMCELL Technologies Inc.
제31장 기타 주요 기업 및 혁신 기업
CYAGEN US INC.
TELA Bio Inc.
RoosterBio Inc.
AdipoSeeds Inc.
Celltex Therapeutics Corporation
Yocon Biology Technology Company
iXCells BIoTechnologies Inc.
LIFELINE CELL TECHNOLOGY LLC
BioRestorative Therapies Inc.
Lipogems International SpA
Cell Applications Inc.
R3 Stem Cell LLC
Stem Cells Care(india) Private Limited
InGeneron Inc.
MITAKY High-Tech Corporation
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
지방 조직 유래 줄기세포 시장(2029년) : 새로운 기회를 제공하는 국가
지방 조직 유래 줄기세포 시장(2029년) : 새로운 기회를 제공하는 부문
지방 조직 유래 줄기세포 시장(2029년) : 성장 전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Adipose tissue-derived stem cells are multipotent mesenchymal stem cells extracted from adipose (fat) tissue that can differentiate into multiple cell types, including adipocytes, osteoblasts, chondrocytes, and myocytes. These cells are easily obtained through minimally invasive procedures and exhibit strong regenerative, anti-inflammatory, and immunomodulatory characteristics.
The primary components of adipose-tissue-derived stem cells include mesenchymal stem cells (MSCs), adipose-derived stem cells (ADSCs), and adipose-stromal cells (ASCs). Adipose-tissue-derived mesenchymal stem cells (MSCs) are multipotent stromal cells isolated from fat tissue that can develop into various cell types, such as bone, cartilage, and fat cells, and play a key role in tissue repair and regeneration. The various types include autologous stem cells and allogeneic stem cells. Applications include regenerative medicine, tissue engineering, cell therapy, and other uses. The primary end users include biotechnology companies and academic and research institutes.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.
The adipose tissue derived stem cell market research report is one of a series of new reports from The Business Research Company that provides adipose tissue derived stem cell market statistics, including adipose tissue derived stem cell industry global market size, regional shares, competitors with a adipose tissue derived stem cell market share, detailed adipose tissue derived stem cell market segments, market trends and opportunities, and any further data you may need to thrive in the adipose tissue derived stem cell industry. This adipose tissue derived stem cell market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The adipose tissue-derived stem cell market size has grown rapidly in recent years. It will grow from $1.07 billion in 2024 to $1.20 billion in 2025 at a compound annual growth rate (CAGR) of 12.7%. The growth in the historic period can be linked to increasing research activities in regenerative medicine, rising prevalence of chronic and degenerative diseases, growing demand for minimally invasive therapies, expanding applications in cosmetic and reconstructive surgeries, and rising government and private funding for stem cell research.
The adipose tissue-derived stem cell market size is expected to see rapid growth in the next few years. It will grow to $1.91 billion in 2029 at a compound annual growth rate (CAGR) of 12.3%. The growth in the forecast period can be driven by a continued rise in chronic and degenerative diseases, a growing geriatric population increasing demand for regenerative treatments, a rise in clinical trials and regulatory approvals for adipose-derived therapies, the expansion of biobanks and stem cell storage facilities, and increasing commercialization of stem-cell-based products. Major trends in the forecast period include progress in personalized regenerative therapies, advancements in manufacturing and scale-up for clinical use, innovation in allogeneic adipose-derived product development, integration of automation and closed-system bioreactors, and advancements in regulatory pathways and standardization.
The increasing demand for alternative therapies is expected to contribute significantly to the growth of the adipose tissue-derived stem cell market going forward. Alternative therapies refer to non-conventional treatments used either in place of or alongside standard medical practices to promote healing and overall well-being. The demand for such therapies is rising due to growing consumer awareness of the potential side effects of conventional medicines, prompting more individuals to seek natural and holistic treatment options that support long-term health. Adipose tissue-derived stem cells align with this trend by promoting natural tissue regeneration and healing, offering a minimally invasive and holistic approach to treating various chronic and degenerative conditions. For instance, in December 2023, according to a report published by Complementary Medicines Australia (CMA), an Australia-based industry association, the complementary medicines industry plays a vital role in supporting health and well-being while contributing significantly to the national economy, with annual revenue reaching approximately $6.4 billion in 2023, marking a 7% increase from 2022. Therefore, the growing demand for alternative therapies is expected to drive the expansion of the adipose tissue-derived stem cell market.
Leading companies in the adipose tissue-derived stem cell market are focusing on advancements in stem cell technologies, such as mesenchymal stem cells, to enhance therapeutic efficacy, safety, and clinical outcomes in regenerative medicine applications. Mesenchymal stem cells (MSCs) are multipotent stromal cells capable of differentiating into various cell types, including bone, cartilage, and adipose cells. They play a crucial role in tissue repair, regeneration, and immune modulation, making them valuable for regenerative medicine and therapeutic applications. For instance, in April 2023, Celltex Therapeutics Corporation, a US-based biotechnology company specializing in adipose-derived stem cell banking and therapy, announced advancements in its proprietary cell expansion technology designed to enhance the viability and therapeutic potential of adipose-derived stem cells for clinical applications. This development marked a significant step forward in strengthening the company's position in the regenerative medicine market and demonstrated its commitment to pioneering safe and effective adipose-derived stem cell therapies aimed at improving patient outcomes across a range of chronic and degenerative conditions.
In November 2023, Global Stem Cells Group Inc., a US-based medical company providing adipose tissue-derived stem cells, partnered with StemBio Co., Ltd. Through this partnership, Global Stem Cells Group, Inc. aims to collaborate with StemBio Co. Ltd. to advance research and development in regenerative medicine by integrating innovative stem cell technologies, expanding clinical applications, and enhancing global access to cutting-edge stem cell therapies for improved patient outcomes. StemBio Co. Ltd. is a South Korea-based biotechnology company specializing in stem cell research, culture media development, and biopharmaceutical innovation for regenerative medicine applications.
Major companies operating in the adipose tissue derived stem cell market are Thermo Fisher Scientific Inc., Takeda Pharmaceutical Company Limited, Merck KGaA, Lonza Group AG, STEMCELL Technologies Inc., CYAGEN US INC., TELA Bio Inc., RoosterBio Inc., AdipoSeeds Inc., Celltex Therapeutics Corporation, Yocon Biology Technology Company, iXCells Biotechnologies Inc., LIFELINE CELL TECHNOLOGY LLC, BioRestorative Therapies Inc., Lipogems International S.p.A., Cell Applications Inc., R3 Stem Cell LLC, Stem Cells Care (india) Private Limited, InGeneron Inc., MITAKY High-Tech Corporation
North America was the largest region in the adipose tissue derived stem cell market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in adipose tissue-derived stem cell report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the adipose tissue-derived stem cell market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The adipose tissue-derived stem cell market includes revenues earned by providing services such as stem cell banking services, contract research services, personalized regenerative therapy services, quality assurance and validation services, and biobanking and logistics services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Adipose Tissue Derived Stem Cell Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on adipose tissue derived stem cell market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for adipose tissue derived stem cell ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The adipose tissue derived stem cell market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
3. Adipose Tissue Derived Stem Cell Market Trends And Strategies
4. Adipose Tissue Derived Stem Cell Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Adipose Tissue Derived Stem Cell Growth Analysis And Strategic Analysis Framework
5.1. Global Adipose Tissue Derived Stem Cell PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Adipose Tissue Derived Stem Cell Market
9.1. China Adipose Tissue Derived Stem Cell Market Overview
9.2. China Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Adipose Tissue Derived Stem Cell Market
10.1. India Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Adipose Tissue Derived Stem Cell Market
11.1. Japan Adipose Tissue Derived Stem Cell Market Overview
11.2. Japan Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Adipose Tissue Derived Stem Cell Market
12.1. Australia Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Adipose Tissue Derived Stem Cell Market
13.1. Indonesia Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Adipose Tissue Derived Stem Cell Market
14.1. South Korea Adipose Tissue Derived Stem Cell Market Overview
14.2. South Korea Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Adipose Tissue Derived Stem Cell Market
15.1. Western Europe Adipose Tissue Derived Stem Cell Market Overview
15.2. Western Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Adipose Tissue Derived Stem Cell Market
16.1. UK Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.1. Germany Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Adipose Tissue Derived Stem Cell Market
18.1. France Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Adipose Tissue Derived Stem Cell Market
19.1. Italy Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Adipose Tissue Derived Stem Cell Market
20.1. Spain Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Adipose Tissue Derived Stem Cell Market
21.1. Eastern Europe Adipose Tissue Derived Stem Cell Market Overview
21.2. Eastern Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Adipose Tissue Derived Stem Cell Market
22.1. Russia Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Adipose Tissue Derived Stem Cell Market
23.1. North America Adipose Tissue Derived Stem Cell Market Overview
23.2. North America Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Adipose Tissue Derived Stem Cell Market
24.1. USA Adipose Tissue Derived Stem Cell Market Overview
24.2. USA Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.2. Canada Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Adipose Tissue Derived Stem Cell Market
26.1. South America Adipose Tissue Derived Stem Cell Market Overview
26.2. South America Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Adipose Tissue Derived Stem Cell Market
27.1. Brazil Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Adipose Tissue Derived Stem Cell Market
28.1. Middle East Adipose Tissue Derived Stem Cell Market Overview
28.2. Middle East Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Adipose Tissue Derived Stem Cell Market
29.1. Africa Adipose Tissue Derived Stem Cell Market Overview
29.2. Africa Adipose Tissue Derived Stem Cell Market, Segmentation By Cell Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Adipose Tissue Derived Stem Cell Market, Segmentation By Types, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Adipose Tissue Derived Stem Cell Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Adipose Tissue Derived Stem Cell Market Competitive Landscape And Company Profiles
